These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23410519)

  • 1. A common MicroRNA signature consisting of miR-133a, miR-139-3p, and miR-142-3p clusters bladder carcinoma in situ with normal umbrella cells.
    Jia AY; Castillo-Martin M; Domingo-Domenech J; Bonal DM; Sánchez-Carbayo M; Silva JM; Cordon-Cardo C
    Am J Pathol; 2013 Apr; 182(4):1171-9. PubMed ID: 23410519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
    Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H
    Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer.
    Pignot G; Cizeron-Clairac G; Vacher S; Susini A; Tozlu S; Vieillefond A; Zerbib M; Lidereau R; Debre B; Amsellem-Ouazana D; Bieche I
    Int J Cancer; 2013 Jun; 132(11):2479-91. PubMed ID: 23169479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA signature for estimating the survival time in patients with bladder urothelial carcinoma.
    Yerukala Sathipati S; Tsai MJ; Shukla SK; Ho SY; Liu Y; Beheshti A
    Sci Rep; 2022 Mar; 12(1):4141. PubMed ID: 35264666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA expression signatures of bladder cancer revealed by deep sequencing.
    Han Y; Chen J; Zhao X; Liang C; Wang Y; Sun L; Jiang Z; Zhang Z; Yang R; Chen J; Li Z; Tang A; Li X; Ye J; Guan Z; Gui Y; Cai Z
    PLoS One; 2011 Mar; 6(3):e18286. PubMed ID: 21464941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder Tumor Subtype Commitment Occurs in Carcinoma
    Wullweber A; Strick R; Lange F; Sikic D; Taubert H; Wach S; Wullich B; Bertz S; Weyerer V; Stoehr R; Breyer J; Burger M; Hartmann A; Strissel PL; Eckstein M
    Cancer Res; 2021 Mar; 81(6):1552-1566. PubMed ID: 33472889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor expression of miR-34a-3p is an independent predictor of recurrence in non-muscle-invasive bladder cancer and promising additional factor to improve predictive value of EORTC nomogram.
    Juracek J; Stanik M; Vesela P; Radova L; Dolezel J; Svoboda M; Slaby O
    Urol Oncol; 2019 Mar; 37(3):184.e1-184.e7. PubMed ID: 30446443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions.
    Schwarz S; Rechenmacher M; Filbeck T; Knuechel R; Blaszyk H; Hartmann A; Brockhoff G
    J Clin Pathol; 2008 Mar; 61(3):272-7. PubMed ID: 17693577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential miRNA expression profiles in bladder urothelial carcinomas.
    Song T; Xia W; Shao N; Zhang X; Wang C; Wu Y; Dong J; Cai W; Li H
    Asian Pac J Cancer Prev; 2010; 11(4):905-11. PubMed ID: 21133599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.
    Itesako T; Seki N; Yoshino H; Chiyomaru T; Yamasaki T; Hidaka H; Yonezawa T; Nohata N; Kinoshita T; Nakagawa M; Enokida H
    PLoS One; 2014; 9(2):e84311. PubMed ID: 24520312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro.
    Dyrskjøt L; Ostenfeld MS; Bramsen JB; Silahtaroglu AN; Lamy P; Ramanathan R; Fristrup N; Jensen JL; Andersen CL; Zieger K; Kauppinen S; Ulhøi BP; Kjems J; Borre M; Orntoft TF
    Cancer Res; 2009 Jun; 69(11):4851-60. PubMed ID: 19487295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification.
    Dyrskjøt L; Kruhøffer M; Thykjaer T; Marcussen N; Jensen JL; Møller K; Ørntoft TF
    Cancer Res; 2004 Jun; 64(11):4040-8. PubMed ID: 15173019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive investigation of aberrant microRNA profiling in bladder cancer tissues.
    Wei Y; He R; Wu Y; Gan B; Wu P; Qiu X; Lan A; Chen G; Wang Q; Lin X; Chen Y; Mo Z
    Tumour Biol; 2016 Sep; 37(9):12555-12569. PubMed ID: 27350368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-199a-3p and miR-214-3p improve the overall survival prediction of muscle-invasive bladder cancer patients after radical cystectomy.
    Ecke TH; Stier K; Weickmann S; Zhao Z; Buckendahl L; Stephan C; Kilic E; Jung K
    Cancer Med; 2017 Oct; 6(10):2252-2262. PubMed ID: 28879675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer.
    Wang S; Li Q; Wang K; Dai Y; Yang J; Xue S; Han F; Zhang Q; Liu J; Wu W
    Clin Transl Oncol; 2013 Oct; 15(10):849-54. PubMed ID: 23408039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA alterations of pancreatic intraepithelial neoplasias.
    Yu J; Li A; Hong SM; Hruban RH; Goggins M
    Clin Cancer Res; 2012 Feb; 18(4):981-92. PubMed ID: 22114139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening biomarkers of bladder cancer using combined miRNA and mRNA microarray analysis.
    Jin N; Jin X; Gu X; Na W; Zhang M; Zhao R
    Mol Med Rep; 2015 Aug; 12(2):3170-6. PubMed ID: 25955758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of a five-microRNA signature in breast carcinoma as a promising biomarker for diagnosis.
    Bitaraf A; Babashah S; Garshasbi M
    J Clin Lab Anal; 2020 Feb; 34(2):e23063. PubMed ID: 31595567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer.
    Nordentoft I; Birkenkamp-Demtroder K; Agerbæk M; Theodorescu D; Ostenfeld MS; Hartmann A; Borre M; Ørntoft TF; Dyrskjøt L
    BMC Med Genomics; 2012 Sep; 5():40. PubMed ID: 22954303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of miRNAs involved in angiogenesis, tumor cell proliferation, tumor suppressor inhibition, epithelial-mesenchymal transition and activation of metastasis in bladder cancer.
    Zaravinos A; Radojicic J; Lambrou GI; Volanis D; Delakas D; Stathopoulos EN; Spandidos DA
    J Urol; 2012 Aug; 188(2):615-23. PubMed ID: 22704449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.